All Stories

  1. Exploring the Effects of Early Censoring and Analysis of Clinical Trial Survival Data on Effectiveness and Cost-effectiveness Estimation through a Case Study in Advanced Breast Cancer

    Article • Medical Decision Making, August 2018, SAGE Publications

    Adrian Bagust

  2. Survival Analysis and Extrapolation Modeling of Time-to-Event Clinical Trial Data for Economic Evaluation

    Article • Medical Decision Making, July 2013, SAGE Publications

    Adrian Bagust

  3. Improving valuation sampling of EQ-5D health states

    Article • Health and Quality of Life Outcomes, January 2013, Springer Science + Business Media

    Adrian Bagust

  4. Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Article • PharmacoEconomics, June 2010, Springer Science + Business Media

    Mr Nigel David Fleeman, Adrian Bagust

  5. The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study

    Article • PLoS ONE, January 2010, PLOS

    Adrian Bagust

  6. The Authors??? Reply

    Article • PharmacoEconomics, January 2006, Springer Science + Business Media

    Adrian Bagust

  7. Accounting for Noncompliance in Pharmacoeconomic Evaluations

    Article • PharmacoEconomics, January 2001, Springer Science + Business Media

    Adrian Bagust

  8. A CIRCULATION MODEL FOR BUSY PUBLIC LIBRARIES

    Article • Journal of Documentation, January 1983, Emerald

    Adrian Bagust